Now that their role in vaccine research is over, 117 chimpanzees in Japan
face an uncertain fate. The chimps were imported in 1975 for a hepatitis B
vaccine programme and are now in a holding facility run by the drug company
Sanwa Kagaku. The company says it can no longer afford the annual £1.5
million upkeep. There are only a few comparable chimp facilities in the world,
and all are government-subsidised. But the Japanese government is reluctant to
take responsibility for the chimps.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
Red-light therapy does have health benefits but not the ones you think
2
Woman in cancer remission without treatment in highly unusual case
3
Man destined for Alzheimer's may have been saved by accidental therapy
4
Where has the deadly hantavirus come from and how does it spread?
5
PCOS postpones perimenopause and allows pregnancies at older ages
6
Hantavirus outbreak will not cause a covid-style pandemic, says WHO
7
A lost ancient script reveals how writing as we know it really began
8
The 50-year quest to create a quantum spin liquid may finally be over
9
300-year-old experiment could become world's best dark matter detector
10
We have figured out a new way to send messages into the past
